Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Kenyon

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases|January 15, 2024
Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of TherapyDaniele Avenoso, Fabio Serpenti, Liron Barnea Slonim, et al.
Leukemia Research|May 3, 2014
Long term follow-up of BEAM-autologous and BEAM-alemtuzumab allogeneic stem cell transplantation in relapsed advanced stage follicular lymphomaVictor Noriega, Harpreet Kaur, Stephen Devereux, et al.
Frontiers in Nutrition|May 24, 2024
Nutritional aspects in autoimmune diseases undergoing hematopoietic stem cell transplantation: overview and recommendations on behalf of the EBMT ADWP and Nurses GroupChiara Gandossi, Helen Jessop, Anne Hahn, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 12, 2023
Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure LymphomaDaniele Avenoso, Amal Alabdulwahab, Michelle Kenyon, et al.
Bone Marrow Transplantation|February 22, 2022
Safe transfer of pediatric patients from hematopoietic stem cell transplant unit into the pediatric intensive care unit: views of nurses and physiciansDaphna Hutt, Eugenia Trigoso Arjona, Hilda Mekelenkamp, et al.
European Journal of Haematology|December 20, 2016
Management of veno-occlusive disease: the multidisciplinary approach to careElisabeth Wallhult, Michelle Kenyon, Sarah Liptrott, et al.
Regulatory Toxicology and Pharmacology : RTP|August 7, 2021
Calculating qualified non-mutagenic impurity levels: Harmonization of approachesJessica C Graham, Mark W Powley, Erika Udovic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2013
Long-term outcomes of alemtuzumab-based reduced-intensity conditioned hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myelogenous leukemia secondary to myelodysplastic syndromeVictoria T Potter, Pramila Krishnamurthy, Linda D Barber, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 26, 2012
Outcome of donor lymphocyte infusion after T cell-depleted allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromesPramila Krishnamurthy, Victoria T Potter, Linda D Barber, et al.
Children (Basel, Switzerland)|August 27, 2021
Specialized Pediatric Palliative Care Services in Pediatric Hematopoietic Stem Cell Transplant CentersHilda Mekelenkamp, Teija Schröder, Eugenia Trigoso, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Mediterranean Journal of Hematology and Infectious Diseases|January 15, 2024
Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of TherapyDaniele Avenoso, Fabio Serpenti, Liron Barnea Slonim, et al.
Leukemia Research|May 3, 2014
Long term follow-up of BEAM-autologous and BEAM-alemtuzumab allogeneic stem cell transplantation in relapsed advanced stage follicular lymphomaVictor Noriega, Harpreet Kaur, Stephen Devereux, et al.
Frontiers in Nutrition|May 24, 2024
Nutritional aspects in autoimmune diseases undergoing hematopoietic stem cell transplantation: overview and recommendations on behalf of the EBMT ADWP and Nurses GroupChiara Gandossi, Helen Jessop, Anne Hahn, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 12, 2023
Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure LymphomaDaniele Avenoso, Amal Alabdulwahab, Michelle Kenyon, et al.
Bone Marrow Transplantation|February 22, 2022
Safe transfer of pediatric patients from hematopoietic stem cell transplant unit into the pediatric intensive care unit: views of nurses and physiciansDaphna Hutt, Eugenia Trigoso Arjona, Hilda Mekelenkamp, et al.
European Journal of Haematology|December 20, 2016
Management of veno-occlusive disease: the multidisciplinary approach to careElisabeth Wallhult, Michelle Kenyon, Sarah Liptrott, et al.
Regulatory Toxicology and Pharmacology : RTP|August 7, 2021
Calculating qualified non-mutagenic impurity levels: Harmonization of approachesJessica C Graham, Mark W Powley, Erika Udovic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2013
Long-term outcomes of alemtuzumab-based reduced-intensity conditioned hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myelogenous leukemia secondary to myelodysplastic syndromeVictoria T Potter, Pramila Krishnamurthy, Linda D Barber, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 26, 2012
Outcome of donor lymphocyte infusion after T cell-depleted allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromesPramila Krishnamurthy, Victoria T Potter, Linda D Barber, et al.
Children (Basel, Switzerland)|August 27, 2021
Specialized Pediatric Palliative Care Services in Pediatric Hematopoietic Stem Cell Transplant CentersHilda Mekelenkamp, Teija Schröder, Eugenia Trigoso, et al.
Pageof 5